ALFA Finder| Management target | Revenue 37.0% FY27 |
|---|
| Revenue growth | Revenue surged 51% YoY to record 320.7 Cr. |
|---|---|
| Margins | Consolidated EBITDA at 23.3%; core units at 28.1% excluding new centers. |
| Demand visibility | Strong demand in NCR and regional clusters like Jhansi-Orchha. |
| Management confidence | Aggressive and confident, focusing on rapid brownfield and greenfield scaling. |
Growth
Revenue grew 51% YoY and EBITDA 39% YoY. Growth is fueled by high-ARPOB specialty mix like oncology.
Outlook
Targeting 5,000 beds in next three to five years; FY27 EBITDA margin guided at 24% and above.
Risks
Expansion-led pressure on PAT margins due to interest and depreciation. Stagnant occupancy at New Delhi/Faridabad units.
Last quarter's promises, checked
Delivered
- EBITDA margin 24-25% → delivered 24.2% (= BEAT)
- Revenue growth ~36% → delivered 36% (= BEAT)
- Faridabad unit break-even by month 10-11 → delivered break-even (= BEAT)
Partly delivered
- Debtor days target 90-95 → delivered 112 (= PARTIAL)
Earnings Call Transcript filed with BSE, NSE: YATHARTH. Summary written with AI assistance from the document.
Yatharth Hospital & Trauma Care Services Ltd: key numbers
- Share price
- ₹1,046.60
- Market cap
- ₹10,084 Cr
- Revenue (annual)
- ₹1,207 Cr
- Net profit (annual)
- ₹175.4 Cr
- P/E (TTM)
- 52.9×Sector 54.5×
- Promoter holding
- 55.80%+0.00% QoQ
- FII holding
- 7.05%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Yatharth Hospital & Trauma Care Services Ltd
All →Yatharth Hospital & Trauma Care Services Preferential Issue
Yatharth Hospital received CCI approval for its proposed ₹3,150 Crore preferential issue to Rasmalai Limited (24.87% stake). This clears a key regulatory hurdle for the capital raise.
- Value
- ₹3,150 Cr
Yatharth Hospital & Trauma Care Services Earnings Call Transcript: Key Takeaways
Yatharth delivered record performance driven by newer acquisitions turning EBITDA positive and a strategic 3,150 Cr Advent partnership to double bed capacity.
- Call
- Guides 30% growth
Yatharth Hospital & Trauma Care Services Investor Presentation: Key Takeaways
Q2 FY27 revenue Rs 4,314 mn (+52% YoY), EBITDA Rs 1,020 mn (23.6% margin), PAT Rs 485 mn (+17% YoY). Advent Rs 3,150 cr primary infusion awaits approvals.
Yatharth Hospital & Trauma Care Services Results Update
Yatharth Hospitals reported a 52% YoY revenue growth to Rs 4,314 million for Q2 FY27. The company also announced a Rs 3,150 crore strategic investment from Advent International.
- Value
- ₹431.4 Cr
- hospital beds
- 3255.0 beds
Yatharth Hospital & Trauma Care Services Q2 FY27 Results: Net Profit ₹48.5 Cr, Up 17.4% YoY
Yatharth Hospital & Trauma Care Services Ltd reported revenue from operations of ₹431.4 Cr (+52.4% YoY) and net profit of ₹48.5 Cr (+17.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹48.5 Cr · +17.4% YoY
Yatharth Hospital & Trauma Care Services Board Meeting Date
Yatharth Hospital intimated that its Board will meet on 3 Nov 2026 to consider Q2 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.